SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-14-415201
Filing Date
2014-11-17
Accepted
2014-11-17 16:32:06
Documents
3

Document Format Files

Seq Description Document Type Size
1 425 d822747d425.htm 425 20471
2 GRAPHIC g822747new11.jpg GRAPHIC 3932
3 GRAPHIC g822747new22.jpg GRAPHIC 2324
  Complete submission text file 0001193125-14-415201.txt   31398
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filed by) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Subject) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-14956 | Film No.: 141228237
SIC: 2834 Pharmaceutical Preparations